Search research articles
Contact Us
Filters
Showing results (11-20 of 96) with videos related to
Page
of 10
Sort By:
Current Opinion in Genetics & Development
|
April 2, 2017
Genetic models of C9orf72: what is toxic?
Thomas G Moens, Linda Partridge, Adrian M Isaacs
EMBO Molecular Medicine
|
May 24, 2017
Specific biomarkers for <i>C9orf72</i> FTD/ALS could expedite the journey towards effective therapies
Rubika Balendra, Thomas G Moens, Adrian M Isaacs
Acta Neuropathologica Communications
|
November 10, 2020
Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
Annelies Quaegebeur, Idoia Glaria, Tammaryn Lashley, et al.
Biochemistry
|
August 15, 2024
Poly-GR Impairs PRMT1-Mediated Arginine Methylation of Disease-Linked RNA-Binding Proteins by Acting as a Substrate Sink
Saskia Hutten, Jia-Xuan Chen, Adrian M Isaacs, et al.
Acta Neuropathologica
|
October 22, 2009
Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene
Ida Elisabeth Holm, Adrian M Isaacs, Ian R A Mackenzie
BMC Medical Genomics
|
May 28, 2017
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
Jack Humphrey, Warren Emmett, Pietro Fratta, et al.
FEBS Letters
|
May 17, 2015
G-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptome
Roberto Simone, Pietro Fratta, Stephen Neidle, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
July 2, 2008
TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander
Gareth T Banks, Anna Kuta, Adrian M Isaacs, et al.
Journal of Neurochemistry
|
December 2, 2021
A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia
Emma L Clayton, Katherine Bonnycastle, Adrian M Isaacs, et al.
The Journal of Gene Medicine
|
July 13, 2012
Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference
Troels Tolstrup Nielsen, Sarah Mizielinska, Lis Hasholt, et al.
Page
of 10
Search research articles
Search
Showing results (11-20 of 96) with videos related to
Sort By:
Page
of 10
Current Opinion in Genetics & Development
|
April 2, 2017
Genetic models of C9orf72: what is toxic?
Thomas G Moens, Linda Partridge, Adrian M Isaacs
EMBO Molecular Medicine
|
May 24, 2017
Specific biomarkers for <i>C9orf72</i> FTD/ALS could expedite the journey towards effective therapies
Rubika Balendra, Thomas G Moens, Adrian M Isaacs
Acta Neuropathologica Communications
|
November 10, 2020
Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity
Annelies Quaegebeur, Idoia Glaria, Tammaryn Lashley, et al.
Biochemistry
|
August 15, 2024
Poly-GR Impairs PRMT1-Mediated Arginine Methylation of Disease-Linked RNA-Binding Proteins by Acting as a Substrate Sink
Saskia Hutten, Jia-Xuan Chen, Adrian M Isaacs, et al.
Acta Neuropathologica
|
October 22, 2009
Absence of FUS-immunoreactive pathology in frontotemporal dementia linked to chromosome 3 (FTD-3) caused by mutation in the CHMP2B gene
Ida Elisabeth Holm, Adrian M Isaacs, Ian R A Mackenzie
BMC Medical Genomics
|
May 28, 2017
Quantitative analysis of cryptic splicing associated with TDP-43 depletion
Jack Humphrey, Warren Emmett, Pietro Fratta, et al.
FEBS Letters
|
May 17, 2015
G-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptome
Roberto Simone, Pietro Fratta, Stephen Neidle, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society
|
July 2, 2008
TDP-43 is a culprit in human neurodegeneration, and not just an innocent bystander
Gareth T Banks, Anna Kuta, Adrian M Isaacs, et al.
Journal of Neurochemistry
|
December 2, 2021
A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia
Emma L Clayton, Katherine Bonnycastle, Adrian M Isaacs, et al.
The Journal of Gene Medicine
|
July 13, 2012
Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference
Troels Tolstrup Nielsen, Sarah Mizielinska, Lis Hasholt, et al.
Page
of 10